Orexin loss in Huntington's disease.
Author
Summary, in English
Huntington's disease (HD) is a devastating neurodegenerative disorder caused by an expanded CAG repeat in the gene encoding huntingtin, a protein of unknown function. Mutant huntingtin forms intracellular aggregates and is associated with neuronal death in select brain regions. The most studied mouse model (R6/2) of HD replicates many features of the disease, but has been reported to exhibit only very little neuronal death. We describe for the first time a dramatic atrophy and loss of orexin neurons in the lateral hypothalamus of R6/2 mice. Importantly, we also found a significant atrophy and loss of orexin neurons in Huntington patients. Like animal models and patients with impaired orexin function, the R6/2 mice were narcoleptic. Both the number of orexin neurons in the lateral hypothalamus and the levels of orexin in the cerebrospinal fluid were reduced by 72% in end-stage R6/2 mice compared with wild-type littermates, suggesting that orexin could be used as a biomarker reflecting neurodegeneration. Our results show that the loss of orexin is a novel and potentially very important pathology in HD.
Department/s
Publishing year
2005
Language
English
Pages
39-47
Publication/Series
Human Molecular Genetics
Volume
14
Issue
1
Links
Document type
Journal article
Publisher
Oxford University Press
Topic
- Medical Genetics
Status
Published
Research group
- Translational Neuroendocrinology
- Basal Ganglia Pathophysiology
- Neural Plasticity and Repair
- Diabetes - Molecular Metabolism
ISBN/ISSN/Other
- ISSN: 0964-6906